Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Braun

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cleveland Clinic Journal of Medicine|February 4, 2009
Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatmentsWilliam E Braun
Cleveland Clinic Journal of Medicine|June 14, 2002
Update on kidney transplantation: increasing clinical success, expanding waiting listsWilliam E Braun
Cleveland Clinic Journal of Medicine|December 23, 2003
BK polyomavirus: a newly recognized threat to transplanted kidneysWilliam E Braun
Cleveland Clinic Journal of Medicine|September 4, 2014
Advances in autosomal dominant polycystic kidney disease-2014 and beyondWilliam E Braun
Journal of Clinical Apheresis|October 22, 2003
Renal transplantation: basic concepts and evolution of therapyWilliam E Braun
Clinical Journal of the American Society of Nephrology : CJASN|August 29, 2009
The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation--evaluation, determinants, and implications for outcomesEmilio D Poggio, William E Braun, Connie Davis
Ophthalmic Plastic and Reconstructive Surgery|May 24, 2007
Rapamycin for treatment of refractory dysthyroid compressive optic neuropathySusie Chang, Julian D Perry, Gregory S Kosmorsky, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Ultra-late antibody-mediated rejection 30 years after a living-related renal allograftDavid Weinstein, William E Braun, Daniel Cook, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot studyWilliam E Braun, Jesse D Schold, Brian R Stephany, et al.
Clinical Transplantation|October 23, 2010
The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing ageJesse D Schold, Titte R Srinivas, William E Braun, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cleveland Clinic Journal of Medicine|February 4, 2009
Autosomal dominant polycystic kidney disease: emerging concepts of pathogenesis and new treatmentsWilliam E Braun
Cleveland Clinic Journal of Medicine|June 14, 2002
Update on kidney transplantation: increasing clinical success, expanding waiting listsWilliam E Braun
Cleveland Clinic Journal of Medicine|December 23, 2003
BK polyomavirus: a newly recognized threat to transplanted kidneysWilliam E Braun
Cleveland Clinic Journal of Medicine|September 4, 2014
Advances in autosomal dominant polycystic kidney disease-2014 and beyondWilliam E Braun
Journal of Clinical Apheresis|October 22, 2003
Renal transplantation: basic concepts and evolution of therapyWilliam E Braun
Clinical Journal of the American Society of Nephrology : CJASN|August 29, 2009
The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation--evaluation, determinants, and implications for outcomesEmilio D Poggio, William E Braun, Connie Davis
Ophthalmic Plastic and Reconstructive Surgery|May 24, 2007
Rapamycin for treatment of refractory dysthyroid compressive optic neuropathySusie Chang, Julian D Perry, Gregory S Kosmorsky, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Ultra-late antibody-mediated rejection 30 years after a living-related renal allograftDavid Weinstein, William E Braun, Daniel Cook, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2014
Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot studyWilliam E Braun, Jesse D Schold, Brian R Stephany, et al.
Clinical Transplantation|October 23, 2010
The relative risk of overall graft loss and acute rejection among African American renal transplant recipients is attenuated with advancing ageJesse D Schold, Titte R Srinivas, William E Braun, et al.
Pageof 3